Document is current
Any future updates will be listed below
-
Authors
Nyirenda, Osward M.
Moyo, Brewster
Divala, Titus
Buchwald, Andrea
Nampota, Nginache
Mungwira, Randy
Nyangulu, Wongani
Mkandawire, Felix
Mwinjiwa, Edson
Mallewa, Jane
Laurens, Matthew B.
Laufer, Miriam K.
van Oosterhout, Joep J.
-
Funding
Funding for this research was provided by:
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
National Institutes of Health (U01AI089342)
- License Information
-
More Information
Article History
Received: 30 July 2025
Accepted: 17 December 2025
First Online: 25 December 2025
Declarations
:
: This study is a secondary data analysis using existing data from the parent trial, which was approved by the Institutional Review Board of the Division of AIDS, and University of Maryland, USA, the College of Medicine Research and Ethics Committee, Blantyre, Malawi and the Pharmacy and Medicines Regulatory Authority, Lilongwe, Malawi. All participants provided written informed consent.
: Not applicable.
: The authors declare no competing interests.
